Archive for February 2020

Hybridisation of RCTs and RWE studies reinforce the benefits of both, while reducing the limitations of traditional study formats The potential of real-world data that provides adequate scientific evidence for regulatory decision-making is being realised Innovative study designs must be developed to unlock this potential Click here to learn more About SVMPharma SVMPharma is an innovative strategic…

Real-world data and evidence provide valuable performance data on a post-approval drug to create a comprehensive clinical snapshot This can later support regulatory and reimbursement decisions and clinical guidelines More and more stakeholders in the pharmaceutical pipeline are recognising the value of real-world data Click here to learn more About SVMPharma SVMPharma is an innovative strategic consultancy,…

  Electronic prescribing records, or EPRs, are a rich untapped source of real-world evidence SVMPharma’s unique EPR real-world studies are one step ahead of the Systemic Anti-Cancer Therapy (SACT) data set Click here to learn more About SVMPharma SVMPharma is an innovative strategic consultancy, specialising in Real World Evidence (RWE) for the pharmaceutical industry. SVMPharma…